Gerson Escamilla-Soto

Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.

Journal of Ethnopharmacology February 10, 2024 Alberto Hernández-león, Raúl Iván Escamilla-Orozco, Aylín R. Tabal-Robles et al. 29 citations

Central nervous system (CNS) diseases can be diverse and usually present with comorbidity, as in the case of depression and anxiety. Despite alternatives like Psilocybe mushrooms for mental health there is no basic research to evidence their CNS benefits. To evaluate the anxiolytic- and antidepressant-like effects, as well as the acute toxicity of P. cubensis mushroom. First, the acute toxicity...